ARCA Biopharma Inc (NASDAQ:ABIO)
| 2.51 Data as of May 21 |  +0.17 / +7.26%Today’s Change | 1.38 Today|||52-Week Range 5.93 | +10.09% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 2.34 |
| Today’s open | 2.39 |
| Day’s range | -- - -- |
| Volume | 56,074 |
| Average volume (3 months) | 121,440 |
| Market cap | $7.5M |
| Dividend yield | -- |
Data as of 3:49pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TELKTelik Inc | +0.00 | +0.37% |
| BSPMBiostar Pharmaceutic... | +0.04 | +5.33% |
| SKBISkystar Bio-Pharmace... | +0.02 | +1.69% |
| TLONTalon Therapeutics I... | +0.03 | +8.17% |
Data as of 3:59pm ET, 05/21/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow, MD, PhD |
Chief Financial & Accounting Officer Patrick M. Wheeler, MBA |
Corporate headquarters Broomfield, Colorado |
Forecasts
